×

Access all guidelines and regulatory updates on

QuriousRI
×

Access all guidelines and regulatory updates on

QuriousRI

Artixio

Product Registration in South Korea | Compliance Support

Life Sciences Product Registration in South Korea

Comprehensive support for securing product approvals and regulatory compliance across all life sciences sectors in South Korea.

Product Registration Consulting Services in South Korea

In South Korea, the regulatory environment for life sciences products requires a thorough understanding of local laws and standards. Artixio offers expert support in securing product approvals, handling complex documentation, and ensuring compliance across all industries, from pharmaceuticals to medical devices.

We handle all aspects of product registration, from initial classification and documentation to submission and post-market compliance. Our local knowledge and international experience help reduce delays and improve approval chances, making us a trusted partner in South Korea’s regulatory space.

Regulatory Authorities in South Korea

Regulatory Body Industry
Ministry of Food and Drug Safety (MFDS) Pharmaceuticals, Medical Devices, Biologics, Cosmetics
Korea Food and Drug Administration (KFDA) Pharmaceuticals, Biologics
Korea Institute of Industrial Technology (KIIT) MedTech, Medical Devices
Korea Health Industry Development Institute (KHIDI) Pharmaceuticals, MedTech, Biologics
Animal and Plant Quarantine Agency (APQA) Veterinary Products, Animal Health

Product Registration Lifecycle in South Korea

We manage the entire lifecycle of product registration in South Korea:
Compliance consulting services company
Initial Product Assessment
Compliance consulting services company
Documentation & Dossier Preparation
Compliance consulting services company
Submission to Regulatory Authorities
Compliance consulting services company
Approval & Licensing
Compliance consulting services company
Post-Market Compliance

Why Choose Artixio for Product Registration in South Korea

FAQs

Do I need local clinical data for product approval in South Korea?
Yes, local clinical data may be required, especially for pharmaceuticals and medical devices, depending on the product’s classification.
Required documents include product classification, technical dossiers, clinical trial data (if applicable), labeling, and manufacturing certificates.
Our team will assess your product based on its category (pharmaceuticals, medical devices, cosmetics, etc.) and determine if MFDS approval is required.
We provide regular updates throughout the process and ensure you are informed at every stage, from submission to approval.

Still Have Questions ?

Get expert answers tailored to your needs.

Specialized Registration Services Across Multiple Industries

Regulatory and compliance expert – Artixio

Pharmaceuticals

Medical device regulatory services – Artixio

MedTech

Cosmetics regulatory consulting – Artixio

Cosmetics

Nutrition regulatory consulting – Artixio

Nutrition

Biologics regulatory consulting – Artixio

Biologics

Veterinary regulatory consulting – Artixio

Veterinary

Regulatory Affairs Across Multiple Countries

India Artixio – Regulatory affairs consulting expert

India

Singapore Artixio – Regulatory affairs consulting expert

Singapore

Mexico Artixio – Regulatory affairs consulting expert

Mexico

Brazil Artixio – Regulatory affairs consulting expert

Brazil

Vietnam Artixio – Regulatory affairs consulting expert

Vietnam

Malaysia Artixio – Regulatory affairs consulting expert

Malaysia

Argentina Artixio – Regulatory affairs consulting expert

Argentina

Colombia Artixio – Regulatory affairs consulting expert

Colombia

Taiwan Artixio – Regulatory affairs consulting expert

Taiwan

China Artixio – Regulatory affairs consulting expert

China

Europe Artixio – Regulatory affairs consulting expert

European

Thailand Artixio – Regulatory affairs consulting expert

Thailand

Indonesia Artixio – Regulatory affairs consulting expert

Indonesia

Philippines Artixio – Regulatory affairs consulting expert

Philippines

USA Artixio – Regulatory affairs consulting expert

USA

Japan Artixio – Regulatory affairs consulting expert

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Orphan Drug Designation in South Korea (MFDS)

Orphan Drug Designation in

Orphan Drug Designation (ODD) is regulated by Ministry of Food and Drug Safety (MFDS)...

February 10, 2026
Biologics and Biosimilars Regulations and Registration in South Korea

Biologics and Biosimilars Regulations

The Korean pharmaceutical market is estimated to be worth $24.3 billion in 2019, and...

February 10, 2026
Nutraceutical Regulation and Registration in South Korea (MFDS)

Nutraceutical Regulation and Registration

Today, we eat to ease hunger and don’t have the time to consider what...

February 10, 2026

Get in touch

×